Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Advanced Drug Delivery Reviews|May 7, 2022
Genetically engineered antibodies and their application to brain deliverySherie L Morrison, Seung-Uon ShinVaccine|January 18, 2003
Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in miceJoon Youb Lee, Dong-Hyeon Kim, Yeonseok Chung, et al.Cancer Immunology, Immunotherapy : CII|July 10, 2012
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretionYu Zhang, Yair Eliav, Seung-Uon Shin, et al.Molecular Cancer Therapeutics|March 12, 2011
Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacySeung-Uon Shin, Hyun-Mi Cho, Jaime Merchan, et al.Scientific Reports|February 23, 2012
Model for in vivo progression of tumors based on co-evolving cell population and vasculatureSehyo C Choe, Guannan Zhao, Zhenyuan Zhao, et al.Cancer Research|December 17, 2010
Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor responseHyun-Mi Cho, Joseph D Rosenblatt, Khaled Tolba, et al.Blood|February 1, 2017
Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicityShruti Bhatt, Salma Parvin, Yu Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 2002
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cellsPatrick P Ng, Jay S Dela Cruz, David N Sorour, et al.Cancer Research Communications|February 5, 2024
Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 SignalingAnkita P Sankar, Hyun-Mi Cho, Seung-Uon Shin, et al.Cancer Immunology, Immunotherapy : CII|October 24, 2007
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transductionHovav Nechushtan, Dien Pham, Yu Zhang, et al.Pageof 2